Clinical Trials Browser

Phase 2 × dostarlimab × Head & Neck × Clear all

NCT07408063 2026-02-12

BeeHive

Phase 2 Not yet recruiting

Squamous Cell Carcinoma of Head and Neck

NCT06062420 2026-01-09

A Platform Study of Novel Immunotherapy Combinations as First-Line Treatment in Participants With PD-L1 Positive Recurrent/Metastatic Squamous Cell Carcinoma of the Head and Neck- GALAXIES H&N-202

Phase 2 Active not recruiting

Squamous Cell Carcinoma of Head and Neck, Head and Neck Neoplasms

NCT04779151 2025-12-01

NIRADO

Phase 2 Terminated

GastrointestinalGenitourinaryHead & Neck

Biliary Tract Neoplasms, Carcinoma, Renal Cell, Head and Neck Neoplasms

NCT04313504 2024-08-01

Study Evaluating the Efficacy of Niraparib and Dostarlimab (TSR-042) in Recurrent/Metastatic HNSCC

Phase 2 Active not recruiting

Head and Neck Neoplasms

NCT04681469 2022-08-04

PRIME

Phase 2 Recruiting

Squamous Cell Carcinoma of Head and Neck